By: Dr. James W. Stark
10/9/14 - There has been much discussion in the news regarding some potentially serious viral infections going around close to home as well as around the world, including Enterovirus D68 and Ebola. In addition, we are entering influenza season, which can also be serious in certain patient populations. This is a good time to revisit some basic infection control principles that all of our patients should be doing to protect themselves and their loved ones.
... moreAt Grand Rounds this week, Senior Research Scientist, Dr. Violaine Harris discussed the clinical need for CSF biomarker testing in MS and reviewed current research into the discovery and validation of CSF biomarkers. She highlighted the research from Tisch MS showing that a specific biomarker called Fetuin-A can be an accurate indicator of disease activity and therapeutic response.
10/6/14 - Visit the link below or www.tischms.org to learn more. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245485/
The IMSMP would like to wish all of those observing with their families, a happy Eid Al Adha!
The IMSMP would like to wish our Jewish patients, friends and supporters an easy fast on this Yom Kippur.
The journal "Neurology® Neuroimmunology and Neuroinflammation," accepted a paper by Dr. Fozia Mir for Publication. Visit the Tisch MS Research Center of New York at www.tischms.org to learn more.
9/16/14 - Medscape Medical News recently reviewed the stem cell research presented at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS/ECTRIMS). Read the full article below.
9/12/14 - Tisch MS Research Center of New York is proud to be featured in the September 2014 issue of “Neurology Today.” The article “Myelinating Oligodendrocytes Derived from Primary Progressive MS Patients: Scientists Developed Faster, More Efficient Methodology,” discusses research focusing on an accelerated protocol to induce stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system....
more9/10/14 - EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis. Tisch MS Research Center of New York is proud to be a participating site in this longitudinal clinical research study. For more information, contact (212) 265-8070 and ask to speak with a Clinical Research Assistant. Read the full press release here:
...
moreBecause you deserve only the best in MS healthcare. Experience the difference.
Join our mailing list today! Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.
* We don’t share your information with anyone.
